|
PDIK1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.367200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.735400E-01 |
| Normal-vs-Stage2 |
8.236400E-01 |
| Normal-vs-Stage3 |
2.002600E-01 |
| Normal-vs-Stage4 |
1.249800E-01 |
| Stage1-vs-Stage2 |
4.994000E-01 |
| Stage1-vs-Stage3 |
2.591400E-01 |
| Stage1-vs-Stage4 |
1.788220E-01 |
| Stage2-vs-Stage3 |
2.181400E-01 |
| Stage2-vs-Stage4 |
1.399240E-01 |
| Stage3-vs-Stage4 |
6.576600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.598820E-01 |
| Normal-vs-AfricanAmerican |
3.205000E-01 |
| Normal-vs-Asian |
6.653600E-01 |
| Caucasian-vs-AfricanAmerican |
8.201600E-02 |
| Caucasian-vs-Asian |
4.484200E-01 |
| AfricanAmerican-vs-Asian |
1.938050E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.242400E-01 |
| Normal-vs-Female |
4.332800E-01 |
| Male-vs-Female |
9.176600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.937400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.926800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.297000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.120600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.006000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.738400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.301800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.595000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.943600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.451400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.796150E-02 |
| Classical-VS-Follicular |
5.175700E-02 |
| Classical-VS-Other |
8.208200E-01 |
| Classical-VS-Normal |
3.993000E-01 |
| Tall-VS-Follicular |
9.008500E-04 |
| Tall-VS-Other |
3.811400E-01 |
| Tall-VS-Normal |
1.787720E-02 |
| Follicular-VS-Other |
4.197600E-01 |
| Follicular-VS-Normal |
4.628600E-01 |
| Other-VS-Normal |
5.863600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.614000E-01 |
| Normal-vs-N1 |
4.953600E-02 |
| N0-vs-N1 |
2.627700E-02 |
|
|
